154 related articles for article (PubMed ID: 22119705)
21. Child, parent, and service predictors of psychotropic polypharmacy among adolescents and young adults with an autism spectrum disorder.
Lake JK; Weiss JA; Dergal J; Lunsky Y
J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):486-93. PubMed ID: 25329798
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting clinicians' decision as to whether to prescribe psychotropic medications or not in treatment of tic disorders.
Kuwabara H; Kono T; Shimada T; Kano Y
Brain Dev; 2012 Jan; 34(1):39-44. PubMed ID: 21288673
[TBL] [Abstract][Full Text] [Related]
23. Psychotropic medication history of inpatient adolescents--is there a rationale for benzodiazepine prescription?
Ilomäki R; Ilomäki E; Hakko H; Räsänen P
Addict Behav; 2011; 36(1-2):161-5. PubMed ID: 21035951
[TBL] [Abstract][Full Text] [Related]
24. Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.
Bachmann CJ; Manthey T; Kamp-Becker I; Glaeske G; Hoffmann F
Res Dev Disabil; 2013 Sep; 34(9):2551-63. PubMed ID: 23747941
[TBL] [Abstract][Full Text] [Related]
25. National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder.
Gerhard T; Chavez B; Olfson M; Crystal S
J Clin Psychopharmacol; 2009 Jun; 29(3):307-10. PubMed ID: 19440093
[No Abstract] [Full Text] [Related]
26. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
[TBL] [Abstract][Full Text] [Related]
27. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.
Esbensen AJ; Greenberg JS; Seltzer MM; Aman MG
J Autism Dev Disord; 2009 Sep; 39(9):1339-49. PubMed ID: 19434487
[TBL] [Abstract][Full Text] [Related]
28. Psychotropic drug use among Icelandic children: a nationwide population-based study.
Zoëga H; Baldursson G; Hrafnkelsson B; Almarsdóttir AB; Valdimarsdóttir U; Halldórsson M
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):757-64. PubMed ID: 20035594
[TBL] [Abstract][Full Text] [Related]
29. Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities.
Lang PO; Hasso Y; Dramé M; Vogt-Ferrier N; Prudent M; Gold G; Michel JP
Age Ageing; 2010 May; 39(3):373-81. PubMed ID: 20378571
[TBL] [Abstract][Full Text] [Related]
30. Use of psychotropic medication in Oklahoma: a statewide survey.
Spreat S; Conroy JW; Jones JC
Am J Ment Retard; 1997 Jul; 102(1):80-5. PubMed ID: 9241410
[TBL] [Abstract][Full Text] [Related]
31. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.
Martin A; Scahill L; Klin A; Volkmar FR
J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):923-31. PubMed ID: 10405512
[TBL] [Abstract][Full Text] [Related]
32. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
[TBL] [Abstract][Full Text] [Related]
33. Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complex.
Chung TK; Lynch ER; Fiser CJ; Nelson DA; Agricola K; Tudor C; Franz DN; Krueger DA
Ann Clin Psychiatry; 2011 Nov; 23(4):263-9. PubMed ID: 22073383
[TBL] [Abstract][Full Text] [Related]
34. Age-related trends in psychotropic medication use among very young children in foster care.
dosReis S; Tai MH; Goffman D; Lynch SE; Reeves G; Shaw T
Psychiatr Serv; 2014 Dec; 65(12):1452-7. PubMed ID: 25082134
[TBL] [Abstract][Full Text] [Related]
35. [Warning about overconsumption of psychotropic drugs in adolescents].
Hansen BB
Soins Pediatr Pueric; 2005 Apr; (223):7. PubMed ID: 15869026
[No Abstract] [Full Text] [Related]
36. Help across the spectrum: a developmental pediatrician's perspective on diagnosing and treating autism spectrum disorders.
Copeland L
J Soc Work Disabil Rehabil; 2012; 11(1):1-32. PubMed ID: 22409636
[TBL] [Abstract][Full Text] [Related]
37. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
[TBL] [Abstract][Full Text] [Related]
38. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
Mallinger JB; Lamberti SJ
J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
[TBL] [Abstract][Full Text] [Related]
39. The use of psychotropic medications in young children: the facts, the controversy, and the practice.
Stubbe DE; Martin A
Conn Med; 2000 Jun; 64(6):329-33. PubMed ID: 10909194
[TBL] [Abstract][Full Text] [Related]
40. Predictors of safety-related enquiries about psychotropic medication in young people and families accessing a medicines information service.
Dean AJ; Witham M; McGuire T
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):179-85. PubMed ID: 19364295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
